News By Tag Industry News * Industry * More Industries... News By Location Country(s) Industry News
| World Pharmaceutical and Biopharmaceutical Market, 2010-2015 now available at ReportsnReportsThis research undertaking is the result of a detailed analysis of the late stage R&D pipeline of the 50 top companies in pharmaceuticals, the companies that produce the lion's share of revenues. While the report looks at the entire pipeline to 2015
By: ReportsnReports.com http://www.reportsnreports.com/ Original Source : Pharmaceutical and Biopharmaceutical Market http://www.reportsnreports.com/ Buy Now : Market Research http://www.reportsnreports.com/ Browse complete Report at : World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies) http://www.reportsnreports.com/ What Will The Pharmaceutical Market Look Like in the Next Five Years? This research undertaking is the result of a detailed analysis of the late stage R&D pipeline of the 50 top companies in pharmaceuticals, the companies that produce the lion's share of revenues. While the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade. Companies such as Pfizer, Merck and Novartis have been unable to ignore the benefits of investing in biotechnology and have focused on a pipeline in this direction through strategic acquisitions and partnerships with biotech companies and/or through their own in-house research efforts. Companies such as Amgen and Genzyme, which specialize in biotechnology, are now competing with a growing number of companies and the lines between pharmaceutical and biotechnology specialty companies are becoming more blended; which is a trend expected to continue to grow. This Kalorama Information market research report, The World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies) captures these trends, extracting sales for all pharmaceutical and biopharmaceutical products (excluding prophylactic vaccines) and providing estimates and forecasts of the world biopharma market. CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Potential Market Opportunity Issues and Trends Affecting Market Leading Compan CHAPTER TWO: INTRODUCTION Global Pharmaceutical Market Pharmaceutical Research & Development Overview Clinical Trial Costs CHAPTER THREE: ISSUES AND TRENDS Biotechnology Drug Development Orphan Drugs Fast Track Drug Status Other Accelerated Methods for Drug Approval Pharmaceutical Regulatory Exclusivity Pediatric Extensions Biopharmaceutical Industry—Biosimilar (Biogeneric) Aging Population Mergers, Acquisitions, and Collaborations Contributors To R&D Success R&D Spending The Role of Contract Research Organizations Sustainability in a changing Pharmaceutical Industry CHAPTER FOUR: WORLDWIDE PHARMACEUTICAL INDUSTRY LEADERS Introduction Pfizer, Inc./Wyeth (merged in 2009) Overview Financial Performance and Investments Late Stage Pipeline Merck & Co., Inc. Overview Financial Performance and Investments Late Stage Pipeline Novartis AG Overview Financial Performance and Investments Late Stage Pipeline Roche Ltd. Overview Financial Performance and Investments Late Stage Pipeline Sanofi-Aventis Overview Financial Performance and Investments Late Stage Pipeline AstraZeneca plc Overview Financial Performance and Investments Late Stage Pipeline GlaxoSmithKline plc Overview Financial Performance and Investments Late Stage Pipeline Johnson & Johnson Overview Financial Performance and Investments Late Stage Pipeline Eli Lilly & Company Overview Financial Performance and Investments Late Stage Pipeline Bristol-Myers Squibb Company Overview Financial Performance and Investments Late Stage Pipeline Abbott Laboratories Overview Financial Performance and Investments Late Stage Pipeline Takeda Pharmaceutical Co., Ltd. Overview Financial Performance and Investments Late Stage Pipeline Bayer AG Overview Financial Performance and Investments Late Stage Pipeline Amgen, Inc. Overview Financial Performance and Investments Late Stage Pipeline Boehringer Ingelheim GmbH Overview Financial Performance and Investments Late Stage Pipeline TEVA Pharmaceutical Industries, Ltd. Overview Financial Performance and Investments Late Stage Pipeline Astellas Overview Financial Performance and Investments Late Stage Pipeline Daiichi Sankyo Overview Financial Performance and Investments Late Stage Pipeline Novo Nordisk Overview Financial Performance and Investments Late Stage Pipeline Eisai Overview Financial Performance and Investments Late Stage Pipeline CHAPTER FIVE: COMPANIES OF INTEREST Introduction Otsuka Late Stage Pipeline Merck KGaA Late Stage Pipeline Gilead Sciences Late Stage Pipeline Mylan Pipeline Baxter International Late Stage Pipeline Chugai Pharmaceutical Company, Ltd. Late Stage Pipeline Mitsubishi Tanabe Late Stage Pipeline Servier, Les Laboratories Pipeline UCB SA Late Stage Pipeline Allergan Late Stage Pipeline Forest Laboratories Late Stage Pipeline Nycomed International Late Stage Pipeline Genzyme Corporation Late Stage Pipeline Biogen Idec Late Stage Pipeline Hospira Late Stage Pipeline Watson Pipeline CSL Limited Late Stage Pipeline Alcon Late Stage Pipeline Shire Late Stage Pipeline Celgene Corporation Late Stage Pipeline Lundbeck Late Stage Pipeline Shionogi & Co., Ltd. Late Stage Pipeline Menarini Group Late Stage Pipeline Dainippon Sumitomo Pharma, Co., Ltd. Late Stage Pipeline Cephalon Late Stage Pipeline Actelion Late Stage Pipeline Procter & Gamble Endo Pharmaceuticals Late Stage Pipeline Ono Pharmaceutical Co. Late Stage Pipeline Purdue Pharma Late Stage Pipeline CHAPTER SIX: MARKET FORECAST Overview Company Analysis Pipeline Snapshot: Top 50 Companies Current Market Value Market Forecast CHAPTER SEVEN: BIOPHARMACEUTICAL MARKET Biopharmaceutical Companies Biopharmaceutical Market Forecast ABBREVIATIONS Browse all : Pharmaceuticals http://www.reportsnreports.com/ Browse all : Kalorama Information http://www.reportsnreports.com/ Browse all : Newly Published http://www.reportsnreports.com/ Related Reports : Global Small Wind (50-350kW) Market Analysis and Forecasts to 2015 http://www.reportsnreports.com/ Global Small Wind (50-350kW) Power Market Analysis and Forecasts to 2015 http://www.reportsnreports.com/ Research Report on Top 50 of Global Tire Manufacturers, 2009-2010 http://www.reportsnreports.com/ 3D IC & TSV Top 50 Profiles http://www.reportsnreports.com/ World E-Paper Display Market: Technologies, Applications, Trends & Forecast (2010 - 2015) http://www.reportsnreports.com/ About Us: ReportsnReports is comprising of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients. Contact: Ms. Sunita 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004 Website: http://www.reportsnreports.com/ Blog: http://reportsnreports.wordpress.com/ # # # ReportsnReports is comprising of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
